Table 1.
Table of basic characteristics of included studies.
| Author name | Number randomized | Male (%) | Age (yr) | Disease duration (yr) | Chinese medicine | Conventional therapy | Treatment duration (wk) |
|---|---|---|---|---|---|---|---|
| Chen JJ 2020 | 41/41 | 50.0 | 55.6 | 2.4 | FFXST 1.5 g tid | Citicoline 0.2–1.0 g qod | 40 |
| Li HL 2012 | 24/23 | 38.3 | / | / | FFXST 1.5 g tid | Nerve Growth Factor 2 mL biw | 42 |
| Li J 2018 | 62/62 | 58.9 | 56.0 | 2.6 | FFXST 1.5 g tid | Citicoline 2 mL qod | 40 |
| Liu CZ 2015 | 43/44 | 44.8 | 45.5 | / | FFXST 1.5 g tid | Mecobalamine 0.5 mg tid | 28 |
| Wang Y 2018 | 54/53 | 67.3 | 59.2 | 1.2 | FFXST 1.5 g tid | VitB1 100 mg qd VitB12 0.25 mg qd Nerve Growth Factor 30 μg qd |
90 |
| Wei QH 2021 | 34/34 | 48.5 | 56.4 | / | FFXST 1.5 g tid | Citicoline 0.2–1.0 g qod | 40 |
| Yu JP 2019 | 45/45 | 54.4 | 58.3 | 1.7 | FFXST 1.5 g tid | Citicoline 2 mL qod | 40 |
| Yuan M 2019 | 30/30 | 53.3 | 65.2 | 1.8 | FFXST 1.5 g tid | Citicoline 2 mL qod | 40 |
| Zhang CF 2021 | 36/35 | 64.8 | 56.1 | / | FFXST 1.5 g tid | Citicoline 0.2–1.0 g qod | 40 |
| Zhang X 2018 | 30/30 | 38.3 | 66.0 | 1.8 | FFXST 1.5 g tid | VitB1 100 mg qd VitB12 0.25 mg qd Nerve Growth Factor 2 mL biw |
21 |
FFXST = Fufang Xueshuantong Capsules.